The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits - Fig 6 by Jin Zhou (90734)

“…<p>The effects of GSK360A on <b>(A)</b> mNSS, <b>(B)</b> beam balance, <b>(C)</b> foot fault and <b>(D)</b> hind limb performance at 5 hours, 1 day, 1 week and 3 weeks after stroke. …”

DPI, NAC and resveratrol decrease lipolysis. by Sarah A. Krawczyk (172699)

The novel <i>carboxylesterase 1</i> variant c.662A>G may decrease the bioactivation of oseltamivir in humans by Jaeseong Oh (3947381)

“…A novel <i>CES1</i> c.662A>G single nucleotide polymorphism (SNP) was predicted to decrease CES1 enzymatic activity in an <i>in silico</i> analysis. …”

This is the raw data of Western blot in Met-5A cell. by Yangyang Yin (14323701)

Subjects:

JARID1B downregulation results in the decrease of cell invasion capability. by Yung-Ting Kuo (736349)

Postnatal CDPPB treatment decreased [¹¹C]PBR accumulation in saline-exposed offspring, but not in offspring prenatally exposed to LPS. by Dany Arsenault (229311)

“…<p>Postnatal CDPPB treatment decreased the accumulation of [¹¹C]PBR in the olfactory bulb, cerebellum, hippocampus, striatum, hypothalamus and the whole brain of the offspring prenatally exposed to saline solution (A). …”

Intracellular ROS decrease mediated by TAT-fused protein delivery. by Cecilia L. Balaban (4424212)

Inhibition of F/P tyrosine kinase by imatinib in CEL patients decreased phosphorylation of JAK2, Stat3 and Stat5 in a time-dependent manner. by Bin Li (39349)

The ATR IR signal decreases with decreasing dilutions of cells. by Allison L. Stelling (392086)

“…<p>Shown is a box plot for serial dilutions of a glioblastoma cell suspension. …”

PA sGCβ expression is persistently decreased after neonatal hyperoxia exposure. by Marta Perez (526067)

Sildenafil treatment during recovery does not affect hyperoxia-induced decreases in alveolar counts. by Marta Perez (526067)

Twenty-four hour monitoring revealed increased interaction and decreased activity during daytime in <i>Cdkl5</i> -/Y mice. by Kosuke Okuda (5150393)

“…The genotype difference during the whole period was significant (p = 0.0012). (ii) Activity level (A.U.). The activity level of <i>Cdkl5</i> -/Y mice is significantly decreased compared to <i>Cdkl5</i> +/Y mice during daytime (p = 0.0004), but not in the nighttime (p = 0.1535). …”

Loss of <i>SLC4A11</i> expression in hCEnC leads to decreased cell barrier function. by Doug D. Chung (3611387)

Disruption of the interaction between AKIP 1A and PKAc decreases phosphorylation of p65 at serine 276 in the cytosol. by Charles C. King (156152)

Percentage of normal/intermediate/poor metabolizers, or persons with decreased or poor transporter function of SLCO1B1 or reduced expression of VKORC1, showing high proportions of... by Riccardo Proietti (15332861)

Reciprocal increase in 5mC and decrease in 5hmC at the pregnancy-associated gene clusters in placentas of obese compared to lean mothers. by Kohzoh Mitsuya (4521304)

“…<p>(A) Reciprocal increase in 5mC and decrease in 5hmC at the <i>GH-CSH</i> gene cluster on human chromosome 17q24. …”

Stroma decreases spheroid size by decreasing cell width. by Karen F. Chambers (224337)

Silencing JARID1B decreases epithelial to mesenchymal transition (EMT). by Yung-Ting Kuo (736349)

JNK inhibitor AS601245 significantly rescued the decrease in p-FOXO3a and attenuated FOXO3a translocation into nucleus after HI with no influence on p-Akt. by Deyuan Li (769599)

Galiellalactone decreases the proportion of ALDH+ prostate cancer cells in vitro and the ALDH1A1 expression in vivo. by Rebecka Hellsten (348459)

“…<p>A. DU145 and LNCaP-IL6 cells were treated with galiellalactone (5–50 µM) for 24 h and subjected to ALDEFLUOR® assay. …”